Table 2.

Outcomes according to the ordinal COVID-19 severity scale by type of disease

	All patients (n=1020)	Giant cell arteritis (n=158)	ANCA-associated vasculitis (n=294)	Polymyalgia rheumatica (n=323)	Behçet's syndrome (n=97)	Other vasculitis (n=148)
Not hospitalised	512 (50·2%)	69 (43·7%)	110 (37·4%)	187 (57·9%)	69 (71·1%)	77 (52·0%)
Hospitalisation with no supplemental oxygen	114 (11·2%)	19 (12·0%)	30 (10·2%)	30 (9·3%)	15 (15·5%)	20 (13·5%)
Hospitalisation with ventilation or supplemental oxygen	239 (23·4%)	38 (24·1%)	89 (30·3%)	71 (22·0%)	11 (11·3%)	30 (20·3%)
Death	155 (15·2%)	32 (20·3%)	65 (22·1%)	35 (10·8%)	2 (2·1%)	21 (14·2%)

Data are n (%). This analysis excludes 182 patients with missing outcome data. ANCA=antineutrophil cytoplasmic antibody.